InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Kutok Jeffery, Directeur Scientifique. Director active across 1 company, notably Epizyme, Inc.. Aggregated, 7 reports have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €8k. Activity tracked since 16 August 2021. The latest transaction was disclosed on 9 August 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
39,046 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028857:0
380,000 shares@ US$1.3998.4% of flowCommon Stock, par value $0.0001SEC:0000899243-22-028417:0
2,741 shares@ US$0.9026.7% of flowCommon Stock, par value $0.0001SEC:0000899243-22-014724:0
2,556 shares@ US$1.3736.6% of flowCommon Stock, par value $0.0001SEC:0000899243-22-004827:0
2,556 shares@ US$1.370.6% of flowCommon Stock, par value $0.0001SEC:0000899243-22-004827
45,832 shares0Common Stock, par value $0.0001SEC:0000899243-21-033406:0
45,832 shares0Common Stock, par value $0.0001SEC:0000899243-21-033406
7 of 7 declarations
About Kutok Jeffery
Jeffery Kutok is the Chief Scientific Officer at Epizyme, Inc. He oversees the company's research and development initiatives, ensuring innovation in treatment areas. His scientific expertise is crucial for Epizyme's success.
